Stories by and About Parents With Disabilities" calls attention to an often overlooked segment of the disabled population.

Learn more about whether Option Care Health, Inc. or Surgery Partners, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A new FTC report found that pharmacy benefit managers have inflated the price of life-saving generic prescription drugs, finding the companies sometimes increased prices of these drugs by 1,000 ...

"With the global stem cell market expanding, we see an opportunity to make these treatments more accessible in the U.S.," ...

Imsidolimab inhibits the function of the IL-36R, compensating for the deficiency of the endogenous IL-36 regulator in patients with GPP. Imsidolimab has successfully concluded its development program ...

The road to menopause hasn't always been clearly defined for the stand-up comedian. But now, with open and honest dialogue, she's normalizing a new season of life for herself and others.